The Menovair Clinical Study

Many herbal supplements claim to help relieve menopausal discomfort, and some have testimonials to support this. However, very few companies are willing to put their products to the test and clinically verify their claims. If they are not willing to scientifically test their product, how do you know if they are really telling the truth?

Here at Nutreance, we do things differently. When designing Menovair, we decided that we only wanted to offer it to the public if it was clinically proven to reduce the frequency and intensity of hot flashes, night sweats, and mood swings.

Once the formula was finalized, we enlisted Princeton Consumer Research to conduct a placebo-controlled clinical study over the course of 30 days. 55 women who described themselves as experiencing discomfort related to menopause took part in the study. 33 participants were given Menovair, while 22 other participants were given a placebo. Each was instructed to take the product daily and keep a daily journal of their experience.

The statistically significant results were as follows:

  • Participants reported significant relief for 15 out of 17 menopausal issues that were evaluated, significantly outpacing placebo.
  • 7 out of 10 participants reported significant reduction in both the frequency and intensity hot flashes and night sweats, resulting in improved sleep quality with fewer interruptions.
  • 2 out of 3 participants reported an improvement in their overall mood, with a majority reporting less frequent mood swings, less irritability, and greater mood stability.

For more details, click here to view the complete results of the study.